MedCity News November 4, 2024
Nutrition isn’t a supplement — it’s foundational to metabolic health. It’s time we integrate more ‘Food as Medicine’ initiatives alongside the GLP-1 therapies that are gaining traction.
GLP-1 receptor agonists, like Wegovy and Ozempic, have taken center stage in obesity and diabetes treatment, praised for their ability to curb appetite, reduce “food noise,” and slow digestion for dramatic weight loss results. While these medications play a strong role in chronic disease management, they’re no replacement for healthy nutrition.
Food itself is one of the best therapeutic tools for long-term health — and it’s certainly less expensive than GLP-1 therapies. In fact, a recent study reveals that nationwide use of Medically Tailored Meals (MTMs) for patients with diet-sensitive conditions, like...
Today's Sponsors
Today's Sponsor